Booster Infusion of T-Cell Depleted, CD34+ Enriched, Donor Cells Results in Sustained Count Recovery for Patients with Poor Graft Function Following Allogeneic Stem Cell Transplantation
Year: 2012
Type: article
Study design: Clinical Trial
Abstract: Poor graft function following allogeneic stem cell transplantation (ASCT) is defined by cytopenias in the presence of complete donor engraftment. Infusion of unselected donor hematopoietic stem cells (HSC) can improve cytopenias but may increase graft versus host disease (GVHD). Here we conducted a single institution prospective study to investigate the feasibility of using “booster” infusions of T-cell depleted, CD34+ enriched donor peripheral blood mononuclear cells mobilized using G-CSF +/- plerixafor to improve the blood counts and decrease transfusion requirements in patients with poor graft function following ASCT.
Institution: Washington University in St. Louis
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W1997121456
